Literature DB >> 10926506

Crystal structure of a phage library-derived single-chain Fv fragment complexed with turkey egg-white lysozyme at 2.0 A resolution.

J Aÿ1, T Keitel, G Küttner, H Wessner, C Scholz, M Hahn, W Höhne.   

Abstract

The three-dimensional structure of the single-chain Fv fragment 1F9 in complex with turkey egg-white lysozyme (TEL) has been determined to a nominal resolution of 2.0 A by X-ray diffraction. The scFv fragment 1F9 was derived from phage-display libraries in two steps and binds both hen and turkey egg-white lysozyme, although the level of binding affinity is two orders of magnitude greater for the turkey lysozyme. The comparison of the crystal structure with a model of the single-chain Fv fragment 1F9 in complex with hen egg-white lysozyme (HEL) reveals that in the latter a clash between Asp101 in lysozyme and Trp98 of the complementarity determining region H3 of the heavy chain variable domain occurs. This is the only explanation apparent from the crystal structure for the better binding of TEL compared to HEL. The binding site topology on the paratope is not simply a planar surface as is usually found in antibody-protein interfaces, but includes a cleft between the light chain variable domain and heavy chain variable domain large enough to accommodate a loop from the lysozyme. The scFv fragment 1F9 recognizes an epitope on TEL that differs from the three antigenic determinants recognized in other known crystal structures of monoclonal antibodies in complex with lysozyme. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926506     DOI: 10.1006/jmbi.2000.3971

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Export of autotransported proteins proceeds through an oligomeric ring shaped by C-terminal domains.

Authors:  Esteban Veiga; Etsuko Sugawara; Hiroshi Nikaido; Víctor de Lorenzo; Luis Angel Fernández
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

2.  Structural basis for recognition by an in vitro evolved affibody.

Authors:  Martin Högbom; Malin Eklund; Per-Ake Nygren; Pär Nordlund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

3.  Structural mechanism for affinity maturation of an anti-lysozyme antibody.

Authors:  Ana Cauerhff; Fernando A Goldbaum; Bradford C Braden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

4.  High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.

Authors:  Ian C Wilkinson; Catherine J Hall; Vaclav Veverka; Jiye Y Shi; Frederick W Muskett; Paul E Stephens; Richard J Taylor; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

5.  Rapid isolation of single-chain antibodies for structural genomics.

Authors:  Colleen Shea; Laura Bloedorn; Mark A Sullivan
Journal:  J Struct Funct Genomics       Date:  2005

6.  Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.

Authors:  Erwin De Genst; Karen Silence; Klaas Decanniere; Katja Conrath; Remy Loris; Jörg Kinne; Serge Muyldermans; Lode Wyns
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

7.  Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway.

Authors:  Juan-Luis Loredo-Varela; Victor Joo; Craig Fenwick; Céline Pellaton; Alex Farina; Navina Rajah; Line Esteves-Leuenberger; Thibaut Decaillon; Madeleine Suffiotti; Alessandra Noto; Khalid Ohmiti; Raphael Gottardo; Winfried Weissenhorn; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2019-05-23       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.